Cardiamin Launches New Consumer Packaging

Cardiamin, a supplement that has been developed with heart health patients in mind, has announced the launch of its new consumer packaging.

The brand, which is manufactured by Corceuticals, is the first daily multivitamin developed by medical professionals that supports nutritional health and well being for those who need to improve their heart health. Cardiamin's new packaging will be featured in its upcoming distribution to major retailers, specialty health food outlets and more.

"We are very happy to unveil this new consumer packaging for Cardiamin, which will go a long way toward marketing our brand and making our supplements a trusted source of nutritional support for our customers," said Roger Edwards, Director of Operations for Cardiamin. "This is an exciting product that has the potential to help millions of people live better, healthier lives."

The supplement is based on the latest scientific evidence from the world's leading heart organizations, including strict guidelines from the American Heart Association and the Heart Failure Society of America. It benefits individuals suffering from heart disease, heart failure and high cholesterol, as well as people with a family history of heart disease and stroke.

The supplement is unique because it provides the nutrients people with heart disease need, while excluding those that may be harmful. Cardiamin contains 1000 mg of Omega-3 fatty acids, 1,000 IU of Vitamin D and other essential minerals, but does not have vitamin K, potassium or high levels of vitamin E, which can sometimes counteract the effects of common heart care medications. The supplement packs all of its vitamins and minerals into two small soft-gel tablets, allowing consumers to avoid taking numerous pills every day.

"Formulated without unproven ingredients, Cardiamin provides the vitamins and nutrients that heart health patients really need," said Mitch Gould, CEO of NPI, the firm responsible for the distribution of Cardiamin. "This brand has a lot of potential to reach consumers all over the United States."

Corceuticals, a division of Nephroceuticals, is made up of leading experts in cardiology, who work together to develop optimal nutritional support based on the latest clinical innovations. Its work involves addressing the problem of micronutrient deficiency for patients with cardiovascular issues.

Source: Corceuticals